UNSPSC 51434953: Methyclothiazide/reserpine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434953 Methyclothiazide/reserpine is a Commodity code that covers pharmaceutical preparations combining methyclothiazide and reserpine, yet recent state and local procurement activity under this code does not reflect that specific formulation. Instead, the single available opportunity shows state and local buyers purchasing advanced life support medications used by emergency medical services — a broader and more active class of pharmaceutical goods than the code's nominal scope suggests. The City of Tampa's Purchasing Department, acting on behalf of Tampa Fire Rescue, issued an IFB in April 2026 for four distinct medication line items (Labetalol HCI, Epinephrine, Adenosine, and Diltiazem vials) with quantities ranging from 330 to 1,810 units per item and an estimated contract value of $40,000. This mismatch between the code's name and the actual work being procured signals that the code sees limited specific activity; broader pharmaceutical or emergency medical supply codes may capture more relevant state and local opportunities in this space.

Activity appears concentrated in Florida, with the Tampa solicitation representing the recent record available. The City of Tampa's IFB (Solicitation 26P00188) closed April 8, 2026, and required sealed bids through the OpenGov eProcurement Portal with award to the lowest responsive, responsible bidder within 120 days of bid opening. The contract term is one year with options to renew for two additional one-year periods, plus unilateral extension rights for up to three 30-day periods. The City designated the opportunity as a Small Local Business Enterprise (SLBE) sheltered market with a 5 percent bid discount for SLBE participation not to exceed $10,000. All medications required nine-month or greater shelf life upon acceptance and delivery within ten calendar days of order, with vendors warranting materials free from defects for 365 days and responsible for pickup and replacement of expired stock. Vendors must submit Safety Data Sheets compliant with OSHA Hazard Communication Standards and accessibility documentation including a VPAT demonstrating WCAG 2.2 Level AA conformance.